Literature DB >> 19755133

Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat.

Masaaki Narita1, Akiko Oyabu, Yoshio Imura, Naoki Kamada, Tomomi Yokoyama, Kaori Tano, Atsuko Uchida, Naoko Narita.   

Abstract

Autism is a behaviorally characterized disorder with impairments in social interactions, as well as stereotyped, repetitive patterns of behaviors and interests. Exposure of rat fetuses to thalidomide (THAL) or valproic acid (VPA) on the ninth day of gestation has been reported as a useful model for human autism. We have shown that early serotonergic neural development is disrupted in these rats. In the current study, we used a radial maze and open field experimental paradigm to investigate whether these rats present behavioral and/or learning aberrations. THAL (500mg/kg), VPA (800mg/kg), or vehicle was administered orally to E9 pregnant rats at 7-10 weeks of age. Although the mean number of correct and incorrect arm choices in the initial eight arm choices did not differ between control and teratogen-exposed groups, achievement of learning (seven or eight consecutive correct choices for 3 consecutive days for individual rats) seemed to be impaired in teratogen-exposed groups. Interestingly, average time to explore the maze task was shorter in the teratogen-exposed groups, indicating that correct choice might be due to mere coincidence (i.e., nonexploratory movement). Unexpectedly, no significant differences were observed in social interaction in these rats. These results indicate that prenatal exposure to THAL and VPA might alter behavior in a manner that is, in part, consistent with human autism. Copyright 2009 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755133     DOI: 10.1016/j.neures.2009.09.001

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  18 in total

1.  Developmental and behavioral alterations in zebrafish embryonically exposed to valproic acid (VPA): An aquatic model for autism.

Authors:  Jiangfei Chen; Lei Lei; Linjie Tian; Fei Hou; Courtney Roper; Xiaoqing Ge; Yuxin Zhao; Yuanhong Chen; Qiaoxiang Dong; Robert L Tanguay; Changjiang Huang
Journal:  Neurotoxicol Teratol       Date:  2018-01-05       Impact factor: 3.763

2.  Proposal of auxiliary diagnosis index for autism spectrum disorder using near-infrared spectroscopy.

Authors:  Kazuki Yanagisawa; Nozomi Nakamura; Hitoshi Tsunashima; Naoko Narita
Journal:  Neurophotonics       Date:  2016-06-09       Impact factor: 3.593

3.  Altered posterior cingulate cortical cyctoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism.

Authors:  Adrian L Oblak; Douglas L Rosene; Thomas L Kemper; Margaret L Bauman; Gene J Blatt
Journal:  Autism Res       Date:  2011-02-28       Impact factor: 5.216

4.  Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats.

Authors:  T Sandhya; J Sowjanya; B Veeresh
Journal:  Neurochem Res       Date:  2012-02-10       Impact factor: 3.996

5.  Prenatal exposure to valproic acid alters Reelin, NGF expressing neuron architecture and impairs social interaction in their autistic-like phenotype male offspring.

Authors:  Karunanithi Sivasangari; Koilmani Emmanuvel Rajan
Journal:  Exp Brain Res       Date:  2022-06-01       Impact factor: 2.064

6.  Neurobehavioral manifestations of developmental impairment of the brain.

Authors:  Michal Dubovický
Journal:  Interdiscip Toxicol       Date:  2010-06

Review 7.  Serotonin-related rodent models of early-life exposure relevant for neurodevelopmental vulnerability to psychiatric disorders.

Authors:  Tamara S Adjimann; Carla V Argañaraz; Mariano Soiza-Reilly
Journal:  Transl Psychiatry       Date:  2021-05-11       Impact factor: 6.222

8.  Multi-parametric profiling network based on gene expression and phenotype data: a novel approach to developmental neurotoxicity testing.

Authors:  Reiko Nagano; Hiromi Akanuma; Xian-Yang Qin; Satoshi Imanishi; Hiroyoshi Toyoshiba; Jun Yoshinaga; Seiichiroh Ohsako; Hideko Sone
Journal:  Int J Mol Sci       Date:  2011-12-23       Impact factor: 5.923

Review 9.  An urgent need for experimental animal model of autism in drug development.

Authors:  Rakesh K Ruhela; Ajay Prakash; Bikash Medhi
Journal:  Ann Neurosci       Date:  2015-01

10.  Environmental risk factors for autism.

Authors:  Rodney R Dietert; Janice M Dietert; Jamie C Dewitt
Journal:  Emerg Health Threats J       Date:  2011-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.